Acute partial transverse myelitis with normal cerebral magnetic resonance imaging: Transition rate to clinically definite multiple sclerosis

Multiple Sclerosis

Volumn 11, Issue 4, 2005, Pages 373-377

  Scott, Thomas F ^a,c   Kassab, Salima L ^b   Singh, Shalu ^b  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b ALLEGHENY GENERAL HOSPITAL   (United States)

^c NONE   (United States)

Author keywords

MRI; Multiple sclerosis; Prognosis; Transverse myelitis

Indexed keywords

OLIGOCLONAL BAND;

ACUTE DISEASE; ADULT; ARTICLE; BRAIN REGION; CEREBROSPINAL FLUID ANALYSIS; CLINICAL ARTICLE; CLINICAL EXAMINATION; CONNECTIVE TISSUE DISEASE; CONTROLLED STUDY; DEMYELINATING DISEASE; DISEASE COURSE; EVOKED VISUAL RESPONSE; FEMALE; FOLLOW UP; HUMAN; LABORATORY TEST; MALE; MULTIPLE SCLEROSIS; MYELITIS; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; RELAPSE; RETROSPECTIVE STUDY; RISK ASSESSMENT; SPINAL CORD;

BRAIN; DISEASE PROGRESSION; HUMANS; MAGNETIC RESONANCE IMAGING; MULTIPLE SCLEROSIS; MYELITIS, TRANSVERSE;

EID: 22144452868     PISSN: 13524585     EISSN: None     Source Type: Journal    
DOI: 10.1191/1352458505ms1194oa     Document Type: Article

References (22)

1. Bashir K, Whitaker JN. Importance of paraclinical and CSF studies in the diagnosis of MS in patients presenting with partial cervical transverse myelopathy and negative cranial MRI. Mult Scler 2000; 6: 312-16.
2. O'Riordan JI, Thompson AJ, Kingsley DPE, MacManus DG, Kendall BE, Rudge P et al. The prognostic value of brain MRI in clinically isolated syndromes of the CNS. A 10-year follow-up. Brain 1998; 121: 495-503.
3. Jacobs LD, Beck RW, Simon JH, Kinkel RP, Brownscheidle CM, Murray TJ et al. Intramuscular interferon beta-1a therapy initiated during a first demyelinating event in multiple sclerosis. N Engl J Med 2000; 343: 898-904.
4. Ford B, Tampieri D, Francis G. Long-term follow-up of acute partial transverse myelopathy. Neurology 1992; 42: 250-52.
5. Scott TF, Bhagavatula K, Snyder PJ, Chieffe C. Transverse myelitis comparison with spinal cord presentations of multiple sclerosis. Neurology 1998; 50: 429-33.
6. Berman M, Feldman S, Alter M, Zilber N, Kahana E. Acute transverse myelitis: incidence and etiologic considerations. Neurology 1981; 31: 966-71.
7. Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983; 33: 1444-52.
8. Poser CM, Paty DW, Scheinberg L, McDonald I, Davis FA, Ebers GC et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983; 13: 227-31.
9. MacDonald WI, Compston A, Edan G, Goodkin D, Hartung HP, Lublin FD et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the Diagnosis of Multiple Sclerosis. Ann Neurol 2001; 50: 121-27.
10. Tranverse Myelitis Consortium Working Group. Proposed diagnostic criteria and nosology of acute transverse myelitis. Neurology 2002; 59: 499-505.
11. Runmarker B, Andersen O. Prognostic factors in a multiple sclerosis incidence cohort with twenty-five years of follow-up. Brain 1993; 116: 117-34.
12. Simnad VI, Pisani DE, Rose JW. Multiple sclerosis presenting as transverse myelopathy: clinical MRI features. Neurology 1997; 48: 65-73.
13. Optic Neuritis Study Group. The 5-year risk of MS after optic neuritis. Neurology 1997; 49: 1404-13.
14. Optic Neuritis Study Group. High- and low-risk profiles for the development of multiple sclerosis with 10 years after optic neuritis. Arch Ophthalmol 203; 121: 944-49.
15. Morrissey SP, Miller DH, Kendall BE, Kingsley DPE, Kelly MA, Francis DA et al. The significance of brain magnetic resonance imaging abnormalities at presentation with clinically isolated syndromes suggestive of multiple sclerosis. Brain 1993; 116: 135-46.
16. Sastra-Garriga J, Tintore M, Rovira A, Grive E, Pericot I, Comabella M et al. Conversion to multiple sclerosis after a clinically isolated syndrome of the brainstem: cranial magnetic resonance imaging, cerebrospinal fluid and neurophysiological findings. Mult Scler 2003; 9: 39-43.
17. Martinelli V, Comi G, Rovaris M, Filippi M, Colombo B, Locatelli T et al. Acute myelopathy of unknown aetiology: a clinical, neurophysiological and MRI study of short- and long-term prognostic factors. J Neurol 1995; 242: 497-503.
18. Dalecky A, Pelletier J, Ali Cherif A, Levrier O, Khalil R. Myélopathies aigu du sujet jeune et sclérose en plaques. Rev Neurol (Paris) 1997; 153: 569-78.
19. Misu T, Fujihara K, Nakashima I, Miyazawa I, Okita N, Takase S et al. Pure optic-spinal form of multiple sclerosis in Japan. Brain 2002; 125: 2460-68.
20. Kira J. Multiple sclerosis in the Japanese population. Lancet Neurol 2003; 2: 117-27.
21. Kim K. Idiopathic recurrent transverse myelitis. Arch Neurol 2003; 60: 1290-94.
22. Yu YL, Woo E, Hawkins BR, Ho HC, Huang CY. Multiple sclerosis amongst Chinese in Hong Kong. Brain 1989; 112: 1445-67.